In addition, the co-deletion of MTAP and CDKN2A were also confirmed in 7–16.7% of NPC samples in previous whole-exome and WGS studies (Supplementary figure 14B)12,14. This evidence concerns the gene MTAP and nasopharyngeal carcinoma.